Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (281-290 of 940) with videos related to

Pageof 94
Sort By:
The Journal of Urology|June 17, 2008
Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancerKim N Chi, Joseph L Chin, Eric Winquist, et al.
European Journal of Cancer|February 1, 1972
Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast diseaseB Brownsey, E H Cameron, K Griffiths, et al.
EMBO Molecular Medicine|March 12, 2021
Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signalingNeetu Saxena, Eliana Beraldi, Ladan Fazli, et al.
Osteoarthritis and Cartilage|June 1, 1995
Articular cartilage proteoglycans in osteoarthritic STR/Ort miceJ D Gaffen, S J Gleave, M V Crossman, et al.
The Prostate|October 16, 2010
Use of irinotecan for treatment of small cell carcinoma of the prostateWei-Lin Tung, Yuwei Wang, Peter W Gout, et al.
BJU International|August 22, 2003
Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour modelT Zellweger, S Kiyama, K Chi, et al.
The Journal of Urology|May 1, 1997
Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor modelM E Gleave, N Sato, S L Goldenberg, et al.
The Prostate|March 17, 2006
Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer modelsSatoko Kojima, David J Mulholland, Susan Ettinger, et al.
Der Urologe. Ausg. A|March 21, 2007
[Stress proteins in prostate cancer. Challenge and promise]B A Hadaschik, S W Melchior, R D Sowery, et al.
Cell Death and Differentiation|March 18, 2025
Correction to: Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switchN Hayashi, J W Peacock, E Beraldi, et al.
Pageof 94

Showing results (281-290 of 940) with videos related to

Sort By:
Pageof 94
The Journal of Urology|June 17, 2008
Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancerKim N Chi, Joseph L Chin, Eric Winquist, et al.
European Journal of Cancer|February 1, 1972
Plasma dehydroepiandrosterone sulphate levels in patients with benign and malignant breast diseaseB Brownsey, E H Cameron, K Griffiths, et al.
EMBO Molecular Medicine|March 12, 2021
Androgen receptor (AR) antagonism triggers acute succinate-mediated adaptive responses to reactivate AR signalingNeetu Saxena, Eliana Beraldi, Ladan Fazli, et al.
Osteoarthritis and Cartilage|June 1, 1995
Articular cartilage proteoglycans in osteoarthritic STR/Ort miceJ D Gaffen, S J Gleave, M V Crossman, et al.
The Prostate|October 16, 2010
Use of irinotecan for treatment of small cell carcinoma of the prostateWei-Lin Tung, Yuwei Wang, Peter W Gout, et al.
BJU International|August 22, 2003
Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour modelT Zellweger, S Kiyama, K Chi, et al.
The Journal of Urology|May 1, 1997
Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor modelM E Gleave, N Sato, S L Goldenberg, et al.
The Prostate|March 17, 2006
Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer modelsSatoko Kojima, David J Mulholland, Susan Ettinger, et al.
Der Urologe. Ausg. A|March 21, 2007
[Stress proteins in prostate cancer. Challenge and promise]B A Hadaschik, S W Melchior, R D Sowery, et al.
Cell Death and Differentiation|March 18, 2025
Correction to: Hsp27 silencing coordinately inhibits proliferation and promotes Fas-induced apoptosis by regulating the PEA-15 molecular switchN Hayashi, J W Peacock, E Beraldi, et al.
Pageof 94